Cargando…
Tissue Transglutaminase but Not Microbial Transglutaminase Is Inhibited by Exogenous Oxidative Substances in Celiac Disease
Enzymatic modification of gliadin peptides by human transglutaminase 2 (TG2) is a central step in celiac disease (CD) pathogenesis. Microbial transglutaminase (mTG) mimics the enzymatic function of TG2 and might play a role in CD. TG2 is inhibited by endogenous oxidative endoplasmic reticulum-reside...
Autores principales: | Stricker, Sebastian, Rudloff, Silvia, De Laffolie, Jan, Zimmer, Klaus-Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879474/ https://www.ncbi.nlm.nih.gov/pubmed/35216364 http://dx.doi.org/10.3390/ijms23042248 |
Ejemplares similares
-
Inhibition of Transglutaminase 2 as a Therapeutic Strategy in Celiac Disease—In Vitro Studies in Intestinal Cells and Duodenal Biopsies
por: Stricker, Sebastian, et al.
Publicado: (2023) -
Mucosal tissue transglutaminase expression in celiac disease
por: Villanacci, Vincenzo, et al.
Publicado: (2009) -
Specificity of Tissue Transglutaminase Explains Cereal Toxicity in Celiac Disease
por: Vader, L. Willemijn, et al.
Publicado: (2002) -
Microbial Transglutaminase Is Immunogenic and Potentially Pathogenic in Pediatric Celiac Disease
por: Torsten, Matthias, et al.
Publicado: (2018) -
Microbial transglutaminase should be considered as an environmental inducer of celiac disease
por: Lerner, Aaron, et al.
Publicado: (2019)